Chenzhong Li

1.0k total citations
20 papers, 605 citations indexed

About

Chenzhong Li is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Chenzhong Li has authored 20 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Nephrology. Recurrent topics in Chenzhong Li's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Diabetes Treatment and Management (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Chenzhong Li is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Diabetes Treatment and Management (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Chenzhong Li collaborates with scholars based in China, United States and Canada. Chenzhong Li's co-authors include Pedro Geraldes, Motonobu Matsumoto, George L. King, Akira Mima, Munehiro Kitada, Christian Rask‐Madsen, Yaoming Xue, Christopher Cahill, Koji Mizutani and Zongji Zheng and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and The FASEB Journal.

In The Last Decade

Chenzhong Li

20 papers receiving 597 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chenzhong Li 287 174 160 133 77 20 605
Nobuo Kajitani 340 1.2× 168 1.0× 127 0.8× 161 1.2× 94 1.2× 10 640
Ryo Kodera 372 1.3× 170 1.0× 138 0.9× 188 1.4× 87 1.1× 16 648
Susumu Takagi 190 0.7× 164 0.9× 126 0.8× 119 0.9× 56 0.7× 11 464
Yoshiki Higashijima 198 0.7× 362 2.1× 164 1.0× 113 0.8× 71 0.9× 24 729
Mako Yasuda‒Yamahara 225 0.8× 246 1.4× 178 1.1× 152 1.1× 44 0.6× 24 694
Junna Yamaguchi 136 0.5× 213 1.2× 176 1.1× 97 0.7× 57 0.7× 16 620
Amanda Mather 506 1.8× 274 1.6× 234 1.5× 270 2.0× 63 0.8× 22 804
Karoline von Websky 339 1.2× 164 0.9× 149 0.9× 130 1.0× 171 2.2× 25 793
Yasushi Kanazawa 113 0.4× 297 1.7× 234 1.5× 65 0.5× 36 0.5× 21 684
Yuri Nishino 441 1.5× 202 1.2× 162 1.0× 131 1.0× 101 1.3× 28 912

Countries citing papers authored by Chenzhong Li

Since Specialization
Citations

This map shows the geographic impact of Chenzhong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenzhong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenzhong Li more than expected).

Fields of papers citing papers by Chenzhong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenzhong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenzhong Li. The network helps show where Chenzhong Li may publish in the future.

Co-authorship network of co-authors of Chenzhong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chenzhong Li. A scholar is included among the top collaborators of Chenzhong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenzhong Li. Chenzhong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhi, D. Song, Dao-Yan Pan, et al.. (2023). A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy. The Journal of Clinical Endocrinology & Metabolism. 109(1). 36–45. 1 indexed citations
2.
Han, Yukun, et al.. (2023). Early warning and diagnosis of liver cancer based on dynamic network biomarker and deep learning. Computational and Structural Biotechnology Journal. 21. 3478–3489. 7 indexed citations
3.
Xu, Lin, Xiang‐He Meng, Xiao Wang, et al.. (2022). Identification of PDXDC1 as a novel pleiotropic susceptibility locus shared between lumbar spine bone mineral density and birth weight. Journal of Molecular Medicine. 100(5). 723–734. 1 indexed citations
4.
Zeng, Yanmei, Meiping Guan, Chenzhong Li, et al.. (2018). Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation. Lipids in Health and Disease. 17(1). 251–251. 16 indexed citations
5.
Wang, Siyu, et al.. (2016). [Comparison of endothelial differentiation capacity of adipose-derived stem cells and bone marrow mesenchymal stem cells from rats].. PubMed. 36(9). 1247–1254. 4 indexed citations
6.
Zeng, Yanmei, Chenzhong Li, Meiping Guan, et al.. (2014). The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms. Cardiovascular Diabetology. 13(1). 32–32. 108 indexed citations
7.
Zheng, Zongji, Xiaomeng Liu, Qianwei Zhao, et al.. (2014). Regulation of UCP1 in the Browning of Epididymal Adipose Tissue byβ3-Adrenergic Agonist: A Role for MicroRNAs. International Journal of Endocrinology. 2014. 1–6. 24 indexed citations
8.
Li, Jingjing, Meiping Guan, Chenzhong Li, et al.. (2014). The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Protects against Dyslipidemia-Related Kidney Injury in Apolipoprotein E Knockout Mice. International Journal of Molecular Sciences. 15(7). 11416–11434. 25 indexed citations
9.
Mima, Akira, Qian Li, Munehiro Kitada, et al.. (2012). Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes. Diabetes. 61(11). 2967–2979. 179 indexed citations
10.
Cao, Ying, Fang Gao, Chenzhong Li, & Yaoming Xue. (2012). Expression of leptin and its long-form receptor in the marginal cutaneous tissues of diabetic foot ulcers. Acta Diabetologica. 49(S1). 205–214. 11 indexed citations
11.
Mima, Akira, Munehiro Kitada, Pedro Geraldes, et al.. (2012). Glomerular VEGF resistance induced by PKCδ/SHP‐1 activation and contribution to diabetic nephropathy. The FASEB Journal. 26(7). 2963–2974. 76 indexed citations
12.
Mima, Akira, Yuzuru Ohshiro, Munehiro Kitada, et al.. (2011). Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney International. 79(8). 883–896. 126 indexed citations
13.
Guo, Yu, Bo Zhu, Chenzhong Li, et al.. (2011). [Hypoadiponectinemia leads to insulin resistance in OLETF rats: a preliminary study].. PubMed. 31(6). 1014–6. 1 indexed citations
14.
Zhu, Bo, et al.. (2011). [Regulation of hepatic lipid metabolism by adiponectin via IRS-2 phosphorylation in OLETF rats].. PubMed. 91(44). 3134–8. 3 indexed citations
15.
Zhu, Bo, Chenzhong Li, Yi Qian, et al.. (2011). [Relationship between visceral fat depot and adiponectin mRNA level in the adipose tissue of OLETF rats].. PubMed. 31(8). 1341–4. 2 indexed citations
16.
Cao, Ying, Yaoming Xue, Chenzhong Li, et al.. (2010). [Epidemiological investigation of diabetes and prediabetes in community residents in the suburbs of Guangzhou].. PubMed. 30(9). 2122–4. 5 indexed citations
17.
Xue, Yaoming, et al.. (2007). [Association of serum interleukin-6 and high-sensitivity C-reactive protein levels with insulin resistance in gestational diabetes mellitus].. PubMed. 27(6). 799–801. 9 indexed citations
18.
Guan, Meiping, et al.. (2005). [Prevalence of microalbuminuria in type 2 diabetic patients with hypertension].. PubMed. 25(2). 234–5. 1 indexed citations
19.
Li, Chenzhong, Yaoming Xue, Fang Gao, & Min Wang. (2004). [Determination of serum highly sensitive C-reactive protein in patients with type 2 diabetes].. PubMed. 24(7). 791–3. 1 indexed citations
20.
Guan, Meiping, Yaoming Xue, Jie Shen, et al.. (2002). [Serum uric acid in type 2 diabetic patients complicated by stroke].. PubMed. 22(1). 70–1. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuo Kajitani Breakdown of academic impact, for papers by Ryo Kodera Breakdown of academic impact, for papers by Susumu Takagi Breakdown of academic impact, for papers by Yoshiki Higashijima Breakdown of academic impact, for papers by Mako Yasuda‒Yamahara Breakdown of academic impact, for papers by Junna Yamaguchi Breakdown of academic impact, for papers by Amanda Mather Breakdown of academic impact, for papers by Karoline von Websky Breakdown of academic impact, for papers by Yasushi Kanazawa Breakdown of academic impact, for papers by Yuri Nishino
Rankless by CCL
2026